View article

COVID-19 has driven the need for timely evidence to inform decision-making. Rapid evidence products can be particularly helpful for decision-makers (eg, citizens, patients, health care providers, policy-makers) during COVID-19. The main types of rapid evidence products include inventories, rapid response briefs, and rapid reviews [1]. In this article, we focus on rapid reviews, which are “a form of knowledge synthesis that accelerates the process of conducting a traditional systematic review through streamlining or omitting specific methods to produce evidence for stakeholders in a resource-efficient manner [2].” In a rapid review, several mechanisms are used to streamline the methods, such as narrowing the scope of the topic, parallelization of tasks (eg, conducting screening and data abstraction simultaneously), using review short cuts (eg, one team member screens citations from the literature search versus two …